美股A股
StockGist
Back
6-K2026-02-17· grok-4-1-fast-non-reasoning

XTLB · XTL Biopharmaceuticals Ltd.

0001213900-26-017282

SEC filing

Summary

On February 17, 2026, XTL Biopharmaceuticals Ltd. convened an Extraordinary General Meeting of Shareholders, which was adjourned due to lack of quorum and rescheduled for February 24, 2026 at 4:00 p.m. Israel time at the offices of Amit, Pollak, Matalon & Co. in Tel Aviv, Israel.

Key takeaways